BECOME A MEMBER
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.
Get Involved
TAKE OUR COURSES
The curriculum brings hands-on practical guidance on how to develop personalized treatment regimens and more.
Risks of Cannabis Smoking
The Science of Cannabis
Combining Cannabis With Other Herbs
Does cannabis have synergy with other plants? James Brent, DDS reviews the literature.
Cannabinoids and hormone receptor-positive breast cancer treatment.
Authors: Luka Dobovišek, Fran Krstanović, Simona Borštnar, Nataša Debeljak
Cancers, 25 February 2020
—
Breast cancer (BC) is the most common cancer in women worldwide. Approximately 70-80% of BCs express estrogen receptors (ER), which predict the response to endocrine therapy (ET), and are therefore hormone receptor-positive (HR+). Endogenous cannabinoids together with cannabin…
Trends in Cannabis Use Among Older Adults in the United States, 2015-2018.
Authors: Benjamin H. Han, Joseph J. Palamar
JAMA Internal Medicine, 24 February 2020
—
With the legalization of cannabis in many states for medical and/or recreational purposes, there is increasing interest in using cannabis to treat a variety of long-term health conditions and symptoms common among older adults. The use of cannabis in the past year by adults 65…
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Authors: Sven G. Meuth, Thomas Henze, Ute Essner, Christiane Trompke, Carlos Vila Silván Published in International Journal of Neuroscience Abstract Objective: To determine whether differences in disability status, spasticity severity,…
Factors Moderating the Association Between Cannabis Use and Psychosis Risk: A Systematic Review.
Authors: Sanne J. van der Steur, Albert Batalla, Matthijs G. Bossong Published in Brain Sciences 12 February 2020 Abstract Increasing evidence indicates a relationship between cannabis use and psychosis…
Lifetime Average Cannabis Use in Relation to Hypertriglyceridemic Waist Phenotype in U.S. Adults: A Population-Based Cross-Sectional Study
Authors: Gerard Ngueta Published in Cannabis and Cannabinoid Research 11 February 2020 Abstract Background and Aims: With a growing number of states legalizing recreational or medical cannabis, prevalence of…
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).
Possible therapeutic applications of cannabis in the neuropsychopharmacology field.
Authors: Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo, Manuel Guzmán
European Neuropsychopharmacology, 10 February 2020
—
Cannabis use induces a plethora of actions on the CNS via its active chemical ingredients, the so-called phytocannabinoids. These compounds have been frequently associated with the intoxicating properties of cannabis preparations. However, not all phytocannabinoids are psychot…
Response to UK Medical Cannabis Guidelines
Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.
Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.
Authors: Valeria Giorgi, Sara Bongiovanni, Fabiola Atzeni, Daniela Marotto, et al
Clinical and experimental rheumatology, January-February 2020
—
OBJECTIVES: To assess any clinical improvement attributable to the addition of medical cannabis treatment (MCT) to the stable (>3 months) standard analgesic treatment of fibromyalgia (FM) patients, the retention rate and any changes in the concomitant analgesic treatment over …